Stocks likely to be in limelight are:Bank of India: S&P revises outlook on Bank of India to Negative from Stable. S&P believes asset quality to continue to weaken over next 12-18 months. Affirmed BBB- long-term and A-3 short-term issuer credit ratings. Indian Overseas Bank: S&P places IOB on credit watch with negative implications. Rating could get downgraded by multiple notches to CCC+. CCC+ is a non-investment grade from current BB+ long-term rating. IOB's mounting credit losses have strained capitalisation. Valecha Engineering: Valecha Engineering gets new order worth Rs 398 crore. This order is for upgradation of national highway in Chhattisgarh worth Rs 309 crore. Order worth Rs 89 crore for rail flyover in Mumbai in a Joint Venture. Orders worth over 5 times current market cap.Aurobindo Pharma: Aurobindo Pharma management at BOFA ML conference, Reiterated Form 483 observations at Unit-7 formulation facility. Form 483 observations are addressable. Form 483 observations not related to any data integrity or quality issues. Secured 3 approvals from US FDA for Unit 7. Expect to receive another 1-2 approvals from US FDA in next 2 weeks. Strides Shasun: High delivery-based selling seen.Titan: Delivery volumes at 2 times 10-day average.Century Textiles: Delivery volumes at 2 times 10-day average.The other stocks in news are IndusInd Bank and Ashok Leyland.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!